Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
27VWcdczukvNecnn
